Roflumilast Suppliers & Bulk Manufacturers
Available Forms: Tablet / Cream
Available Strengths: 250 mcg, 500 mcg, 0.05%, 0.15%, 0.3%
Reference Brands: Daliresp (USA), Zoryve (USA)
Category:
Respiratory Disorder
Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor used for the treatment of severe chronic obstructive pulmonary disease (COPD) with chronic bronchitis to reduce the risk of exacerbations. It works by reducing inflammation in the lungs, improving airflow, and decreasing the frequency of COPD flare-ups.
Roflumilast is available in Tablet / Cream
and strengths such as 250 mcg, 500 mcg, 0.05%, 0.15%, 0.3%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Roflumilast is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Roflumilast can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing